Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00845156 · ClinicalTrials.gov registry record · NA
Alpha Lipoic Acid and Insulin Resistance
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT00845156 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 68 participants.
The verdict
NCT00845156, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
Subjects will be screened with a 2 hour oral glucose tolerance test. After this screening visit, their insulin resistance will be measured. Subjects will then be given either alpha lipoic acid (antioxidant) or placebo for 6 weeks. The insulin resistance test will be repeated after the 6 weeks. We believe these studies will confirm the beneficial effect of alpha lipoic acid on insulin sensitivity.
Interventions
- DIETARY_SUPPLEMENT Alpha Lipoic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00845156
The ClinicalTrials.gov registry entry for NCT00845156 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alpha Lipoic Acid is the first listed.
NCT00845156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00845156 about?
NCT00845156 is a clinical study titled "Alpha Lipoic Acid and Insulin Resistance". Subjects will be screened with a 2 hour oral glucose tolerance test. After this screening visit, their insulin resistance will be measured. Subjects will then be given either alpha lipoic acid (antioxidant) or placebo for 6 weeks. The insulin resistance test will be repeated after the 6 weeks. We be...
What is the current status of trial NCT00845156?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2008-01. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00845156?
The interventions under investigation include: Alpha Lipoic Acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00845156?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.